Drug · DIN 02457660
JAMP-AMITRIPTYLINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 10, 2024; first marketed June 10, 2024.
- Drug Identification Number (DIN)
- 02457660
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Amitriptyline N06AA09
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMITRIPTYLINE HYDROCHLORIDE | 75 MG |
Other DINs named JAMP-AMITRIPTYLINE
- DIN 02457679 · Marketed
- DIN 02457687 · Marketed
- DIN 02457695 · Marketed